Merck KGaA hands off its CAR-T R&D operations to Intrexon in $175M deal

Merck KGaA hands off its CAR-T R&D operations to Intrexon in $175M deal

Source: 
Endpoints
snippet: 

Merck KGaA is bowing out of the CAR-T development business, handing over its rights to Intrexon $XON in exchange for $150 million batch of stock.